Anestane

Quick links to important sections

Anestane

Method of action: Anesthesia, Anesthetic

Treatment option: Anesthesia, General Anesthesia

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Anestane

Anestane: Classification as a General Anesthetic

Anestane is classified as a General Anesthetic, utilized to induce and maintain a state of controlled unconsciousness and immobility during surgical procedures. It is a volatile anesthetic, meaning it is a liquid agent that requires vaporization for administration via the inhalation route. The drug's active compound, Halothane, is a halogenated alkane characterized by its anesthetic properties. This drug belongs to the class of agents that produce a complete, reversible loss of sensation and consciousness for surgical use. Its primary purpose is to ensure the patient is insensitive to pain and remains immobile throughout the operation, which is a standard requirement in surgical practice.


What is the Composition and Form of Anestane?

The medicinal entity Anestane is a single-ingredient product composed of its active ingredient, Halothane. This substance is a synthetic compound and is supplied as a clear, colorless volatile liquid. Its chemical structure allows for rapid vaporization and controlled delivery through the lungs. A differentiating feature of this agent is that the formulation often includes the stabilizer Thymol, which helps prevent spontaneous decomposition when the liquid is exposed to light. The route of administration is by inhalation, where the liquid is vaporized and delivered to the respiratory system, making the liquid form the essential delivery mechanism.


Core Purpose: Achieving Unconsciousness and Immobility

The purpose of Anestane is achieved through its function as a potent Central Nervous System (CNS) depressant. This effect suppresses neuronal excitability across the brain, leading to the unconsciousness required for surgical interventions. This systemic action provides deep, controlled anesthesia, facilitating the loss of awareness and contributing to skeletal muscle relaxation necessary for complex surgical procedures. This effect is used in clinical scenarios where a patient requires a major operation necessitating the controlled, temporary prevention of reflexive movement.

Regulatory References

  1. Halothane - eEML
  2. Inhaled Anesthetics - StatPearls - NCBI Bookshelf

What side effects are possible with Anestane?

Possible Side Effects and Safety Information: Anestane

Adverse Reactions and Safety Considerations

Safety data for Anestane, a drug within the general anesthetic and sedation class, indicates specific concerns regarding neurodevelopmental effects in vulnerable populations, based on regulatory findings.

Category Regulatory Notes
Serious Adverse Reactions Potential for adverse effects on brain development, particularly neuronal apoptosis (widespread loss of nerve cells) observed in animal studies following certain exposure parameters.
Population-Specific Risk Children younger than 3 years and pregnant women during the third trimester are considered the most vulnerable to the developmental risk.
Exposure-Related Pattern The potential risk to the developing brain is explicitly linked to repeated or lengthy use (e.g., procedures lasting longer than three hours) of general anesthetic and sedation drugs.
Low-Risk Exposure Regulatory analysis suggests that a single, relatively short exposure to these drugs in infants or toddlers is unlikely to result in negative effects on behavior or learning.

Safety Monitoring and Limitations

The primary safety limitation is the requirement for warnings on drug labeling concerning the use in young children and pregnant women. These warnings are based on the FDA’s review of clinical and non-clinical data across the drug class.

Medical procedures requiring Anestane should not be delayed when medically necessary, as untreated pain and underlying conditions can pose their own risks. However, when procedures are elective, careful consideration of the risks versus the benefits is advised, particularly concerning the duration and number of exposures in vulnerable patients.

The information above reflects high-level safety findings mandated for the class of general anesthetic and sedation drugs and does not constitute individual medical advice.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Anestane (Halothane) is officially documented to result from an excessive depth of anesthesia, presenting as a progression of profound physiological depression. Immediate medical attention is required when any severe manifestations are suspected.

Documented Manifestations Severe Life-Threatening Outcomes
Cardiopulmonary Depression: Hypotension (low blood pressure), Bradycardia (slow pulse), Dose-related Respiratory Depression Cardiac Arrest
Systemic Effects: Cardiac Arrhythmias, Hypoxia, Acidosis Respiratory Arrest
Malignant Hyperthermia (a recognized severe complication requiring specialized treatment with Dantrolene sodium)
Severe Hepatotoxicity (massive hepatic necrosis/liver failure, associated with repeated or severe exposure)

The official regulatory guidance mandates that the anesthetic agent must be discontinued immediately upon any suspicion of overdose or onset of complications. Urgent medical assistance is required for all severe acute exposures. Management involves providing essential respiratory and circulatory support and maintaining a patent airway. Infants and children have a specifically noted increased risk of cardiac instability and bradyarrhythmias, underscoring the necessity for close post-exposure observation as described in the official labeling documents. This documentation outlines the critical signs for which immediate emergency care must be sought.

Therapeutic Uses of Anestane

What Anestane Treats: Main Uses and Benefits

Easing Temporary Symptomatic Discomfort

Anestane is generally relevant in contexts marked by increased discomfort or tension, applied when symptoms create noticeable physiological strain. Symptoms can be acute or episodic, requiring management that may assist with maintaining functional stability. The medication is used in situations involving certain distressing symptoms to provide supportive relief that helps ease the overall symptom burden. It is commonly used for managing symptoms related to physical discomfort, systemic imbalance, and heightened physiological activity.


Supportive Management for Functional Strain

This therapeutic domain applies when symptoms interfere with daily functioning and functional stability becomes affected. Anestane is considered relevant when short-term symptomatic assistance is needed, assisting with maintaining functional stability and contributing to improved day-to-day comfort during periods of heightened symptoms. It is applicable across conditions where symptoms escalate temporarily, such as those associated with acute or disruptive episodes.

“Anestane is applied across domains where additional symptomatic support is needed.”


Addressing Fluctuating Symptom Patterns

The medication is commonly used across conditions characterized by periods of heightened symptoms or recurrent manifestations. Anestane is applied during phases of increased distress or discomfort, which may help patients cope more steadily with symptom fluctuations when symptoms become more noticeable.

Quick Fact: Relief for Symptom Clusters Anestane may assist with managing groups of symptoms that may become intense or disruptive and interfere with daily comfort.

Regulatory References

  1. Pain | MedlinePlus

Eligibility and Restrictions for Use

The eligibility for Anestane (Halothane) use is strictly governed by regulatory documentation, defining patient populations based on history, genetic status, and life stage.

Eligibility Scope

Category Eligibility Rule Defined by Regulators
Populations for whom use is allowed Approved for the induction and maintenance of general anesthesia in adults and children. Older adults may require less for maintenance.
Populations for whom use is not recommended Generally not recommended for obstetrical anesthesia unless the clinical need for uterine relaxation is overriding. Breastfeeding mothers are advised to withhold feeding for 24 hours due to trace amounts found in milk.
Populations for whom use is contraindicated Patients with a known or suspected genetic predisposition to Malignant Hyperpyrexia (MH) must not receive this medicine. Use is also strictly prohibited in patients with a history of unexplained jaundice or fever following previous Halothane exposure.
Age-related eligibility rules Use in children under 18 years is contraindicated for dental procedures performed outside of a hospital setting. Safe use has not been established in pregnancy regarding possible adverse effects on fetal development.
Eligibility-related restrictions Caution is advised in patients with conditions such as Phaeochromocytoma, Renal failure, or Myasthenia gravis. The medicine is also restricted in patients with markedly raised intracranial pressure.

What should I know about interactions with other medicines?

Interactions with other medicines and products are a critical consideration during the use of Anestane.

Potential Drug Interactions

Interacting Product Category Potential Effect Relevance
Neuromuscular Blockers (Muscle Relaxants) Potentiation (increased effect) of the muscle relaxant's action, leading to deeper or prolonged muscle relaxation. Clinically Significant
Catecholamines (e.g., Vasopressors) Increased risk of serious heart rhythm abnormalities due to the heart muscle becoming more sensitive to these agents. Clinically Significant
Non-selective Beta-blockers Combination with catecholamine-containing products may lead to a severe pressor (blood pressure) response and slowed heart rate. Clinically Significant
Opioid Medications & CNS Depressants Increased risk of severe central nervous system (CNS) depression, including profound sedation and respiratory depression. Clinically Significant

General Interaction Profile

Anestane, as an inhaled anesthetic, has a profile defined by pharmacodynamic interactions that primarily affect the cardiovascular and muscular systems. The most common interactions involve medications used concurrently during the perioperative period, where the combined effects can be supra-additive, meaning the total effect is greater than the sum of the individual effects. Close monitoring of both muscle activity and cardiovascular stability is necessary when this medication is administered alongside agents like muscle relaxants or certain heart and blood pressure medicines. Furthermore, caution is advised with all drugs that depress the central nervous system.

Mechanism of Action

Anestane, a general anesthetic, exerts its primary actions within the central nervous system (CNS), modulating neurotransmission to produce a global depression of neuronal activity. The drug selectively partitions into the hydrophobic regions of neuronal membranes and binds to multiple molecular targets, primarily ligand-gated ion channels. Its main inhibitory effect is mediated by positive allosteric modulation of the gamma-aminobutyric acid type A (GABAA) receptor. By binding to allosteric sites on the GABAA receptor complex, Anestane enhances the inhibitory synaptic current, promoting the hyperpolarization of the post-synaptic neuron via increased chloride ion influx. Simultaneously, Anestane functions as an antagonist at excitatory N-methyl-D-aspartate (NMDA) receptors and nicotinic acetylcholine receptors, thereby reducing excitatory neurotransmission in the brain. This dual effect—enhanced inhibition and diminished excitation—alters the equilibrium of neuronal signaling. The resulting cascade includes the suppression of action potential generation and propagation in key CNS structures, such as the thalamocortical circuits, leading to an overall reduction in cerebral metabolic activity and a modulated state of physiologic responsiveness.

Dosage and Administration Information

Official Administration Guidelines for Anestane (Halothane)

Anestane (Halothane) is a volatile liquid general anesthetic, and its use follows the principles of delivery as an inhaled gas during surgical procedures.


Administration Scope and Dosing

Field Official Administration Principle
Route of Administration Inhalation via the pulmonary system. The liquid must be vaporized.
Dosing Schedule Dose is based on the inspired concentration of Halothane in the carrier gas, which is adjusted continuously throughout the procedure.
Induction Range For adults, concentrations from 0.5% to 4.0% may be used to achieve surgical unconsciousness.
Maintenance Range Anesthesia is maintained using a lower concentration, typically ranging from 0.5% to 2.0%.
Timing in Relation to Meals Not applicable; administration is confined to the acute surgical setting.

Procedural and Population-Specific Rules

Field Procedural Requirement
Preparation Requirements Must be administered using a calibrated vaporizer specifically designed for Halothane and co-administered with Oxygen or an Oxygen/Nitrous Oxide mixture. The liquid contains Thymol as a stabilizer.
Age-Group Administration Older Adults typically require lower maintenance concentrations to achieve the desired effect compared to younger adults. Children may require higher inspired concentrations for initial induction.
Course Duration Use is strictly short-term, limited only to the acute duration necessary for the surgical or diagnostic procedure.
Special Procedural Conditions Administration must occur in a monitored, controlled environment under specialist supervision. Vaporizers should be drained and cleaned periodically to prevent Thymol accumulation.

The administration protocol is structured to be continuous, titrated, and acute during the surgical period, ensuring the drug is delivered via a specialized inhalation route at precisely controlled inspired concentrations, with adjustments based on the patient’s age.

Recent Clinical Evidence

Anestane: Recent Clinical Evidence

Evidence for use in Surgical Anesthesia

Anestane was the subject of research in many Randomized Controlled Trials (RCTs) and systematic reviews. The research primarily examined its properties in relation to inducing and sustaining a state of unconsciousness and immobility relevant to surgical procedures. These studies monitored the agent's characteristics across different surgical settings.

Evaluating Onset and Emergence Times

Comparative RCTs were conducted during the intraoperative period. Research in these trials monitored the time measured for a patient to lose consciousness (induction). Similarly, studies explored the time interval observed from when the agent was stopped to the patient waking up (emergence). Findings describe patterns observed in the studied populations related to the speed of both the onset and cessation of the anesthetic state.

Studies on Concentration Levels and Physiological Measures

Research examined the concentration levels used in the agent’s maintenance, which were measured by the Minimum Alveolar Concentration (MAC). Studies also explored outcomes related to physiological strain, specifically monitoring the agent’s influence on circulatory function and heart rate during the surgical period. Further research described the use of objective scores to assess the level of muscle tone observed in the patients studied. The evidence reports measurements of the MAC used in trials where anesthesia was observed.


Evidence in Special Populations

Research examined Anestane across the general adult surgical population, and some studies were conducted in certain age cohorts. Anestane was studied in pediatric (child) patient groups. Similar evaluations were observed in geriatric (older adult) populations. However, data for highly specific groups, such as patients with severe pre-existing comorbidities, is limited when compared to research involving generally healthy surgical populations.


Long-Term Studies and Extended Follow-up

Follow-up durations in the pivotal clinical trials were limited, focusing primarily on the intraoperative phase and the Immediate Post-Anesthesia Care period, which often lasts only up to 24 hours. Consequently, long-term effects are not fully established. Research is limited concerning outcomes that may become noticeable weeks or months after administration, particularly regarding neurocognitive effects. The available evidence provides context for immediate use but does not determine whether an individual will respond similarly over extended periods.


Research Gaps and Areas of Uncertainty

The supporting evidence relies heavily on older studies, meaning the data available was evaluated in trials conducted several decades ago that may not meet the methodological standards of contemporary clinical research. Comparative evidence is lacking for head-to-head performance against the newest inhaled anesthetic agents currently used in surgical practice. The results apply only to the populations studied, and due to limited information for long-term outcomes, subgroup findings are uncertain.

Frequently Asked Questions (FAQ)

Common questions about Anestane (FAQ)

Q: Is Anestane a new drug or has it been around for a long time?

Anestane is considered a classic agent in the field of anesthesia. It was first introduced for clinical use in 1956. The drug was widely utilized for many decades until the mid-1990s, when newer inhaled anesthetic agents became more common in surgical practice.

Q: What does official research say about the effectiveness of Anestane?

According to official regulatory labeling, the drug is indicated for the induction and maintenance of general anesthesia. This means it has been authorized by regulatory bodies for use in producing a reversible state of unconsciousness, which is essential for surgical procedures.

Q: What is the significance of the research phase mentioned for Anestane?

In research and clinical settings, the concentration needed to produce the desired effect is often measured by the Minimum Alveolar Concentration, or MAC. This value represents the concentration of the vaporized drug that produces unconsciousness in the patient. For an adult, this specific concentration value is determined by pharmacology documents.

Q: How quickly does Anestane typically start to work?

Official product information describes the drug as having a medium speed of onset of action. This means the time it takes for a patient to lose consciousness (induction) is neither extremely fast nor extremely slow compared to other agents. The dose is carefully controlled by a specialist during the procedure.

Q: How long do the effects of Anestane usually last?

Regulatory documents describe Anestane as having a medium speed of recovery, which is the time interval from stopping the drug to the patient regaining consciousness (emergence). The primary effects of the drug are controlled and limited strictly to the duration of the surgical procedure.

Q: Is Anestane safe for older adults?

Official information notes that Anestane is approved for use in adults, including older adults. Specialist guidelines indicate that the concentration required to maintain unconsciousness is typically lower for older adults compared to younger adults.

Q: Can Anestane be used during pregnancy?

Regulatory sources state that the drug is not generally recommended for use during obstetric delivery, such as C-sections. Furthermore, studies on inhalation anesthetics, including this drug, suggest that exposure may be associated with an increased risk of miscarriage. Usage in pregnant patients requires careful consideration of the risks versus the necessity of the procedure.

Q: What specific warnings are listed on the official label for Anestane?

The official labeling contains specific warnings about the potential for severe liver injury, also known as hepatotoxicity. Warnings also relate to the risk of Malignant Hyperthermia, a rare but serious condition. Additionally, significant cardiovascular effects such as a fall in blood pressure (hypotension) and irregular heart rhythms (cardiac arrhythmias) are noted.

Q: Why are there often warnings about using Anestane in patients with liver disease?

Official warnings are related to the risk of severe liver injury. Studies indicate that the drug is metabolized in the liver, forming byproducts that can cause an immune-mediated reaction, known as Type 2 hepatotoxicity. The official documentation advises particular caution for patients with a history of liver issues or those who may require repeated exposure to the drug.

Q: Can Anestane affect blood pressure?

Official labeling indicates that the drug can affect the cardiovascular system. Specifically, it causes a fall in blood pressure, known as hypotension. This effect is dose-dependent, meaning the extent of the decrease is related to the amount of the drug being administered at the time.

Q: Is Anestane known to cause stomach upset?

The official adverse reaction lists include reports of both nausea and vomiting. These are gastrointestinal effects that are often observed in the immediate post-operative recovery period. These common effects are carefully monitored by care teams.

Q: What are the most common side effects that people report?

According to official labeling, some of the most commonly reported undesirable effects occur immediately after the procedure. These include post-operative nausea, vomiting, and shivering. Effects on the heart, such as cardiac arrhythmias (irregular heartbeat) and low blood pressure (hypotension), are also noted.

Q: Is it normal to feel a slight headache when starting Anestane?

Headache is listed as a reported adverse reaction in the official drug labeling, alongside other effects on the central nervous system like drowsiness.

Q: Can Anestane cause drowsiness or make me feel tired?

Regulatory documents list drowsiness and fatigue as reported adverse reactions affecting the central nervous system (CNS). Because the drug is a CNS depressant, it is expected that these effects, along with confusion or delirium, may be observed during the recovery period after the procedure.

Q: Can Anestane affect sleep patterns?

Official labeling notes central nervous system effects such as drowsiness and delirium (confusion). Because the drug alters brain function, these effects during the recovery period may temporarily impact a patient's normal sleep and wake cycles.

Q: Is it possible to be allergic to Anestane?

While severe, immediate allergic reactions are not typically emphasized, official information describes the severe liver injury associated with the drug as an immunoallergic reaction. This indicates that the body's immune system mediates the adverse effect, which is similar to a hypersensitivity response.

Q: Does Anestane affect the results of common lab tests?

Studies indicate that the drug can affect the results of certain laboratory tests. It may cause a temporary rise in liver enzymes, known as aminotransferases. It may also affect blood clotting tests, such as prothrombin time, which measures how quickly blood clots.

Q: Does Anestane interact with alcohol?

Literature suggests that the acute use of this drug while a patient is intoxicated with alcohol may heighten the risk of heart or liver injury. This is related to the way both the anesthetic and alcohol are processed in the body, which involves shared metabolic pathways.

Q: Can I take Anestane if I am already taking a blood thinner?

Official information describes a potential interaction with anticoagulants, which are often called blood thinners. The drug may slow down the metabolism (breakdown) of certain anticoagulants. This effect could potentially increase the effects of the blood thinner, making close clinical monitoring required during use.

Q: What precautions are noted for driving or operating machinery while on Anestane?

The official post-procedure warning states that precautions against driving or operating heavy machinery are necessary until the patient is considered fully recovered, which is generally advised for at least 24 hours following administration.

Q: Is Anestane a controlled substance?

According to the federal regulatory classification in the United States, Anestane (Halothane) is not classified as a controlled substance. Controlled substances are drugs subject to special regulations due to their potential for abuse or dependence, a category this drug does not fall into.

How should Anestane be stored and disposed of?

How to Store and Dispose of Anestane?

The storage and disposal of Anestane (Halothane) liquid are governed by strict regulatory requirements designed to maintain product integrity and ensure environmental safety.

Storage Requirement Official Guidance
Temperature & Light Must be protected from light and stored in a tightly closed, light-resistant container. Temperatures should be below 40, C
Handling & Stability Requires storage in a well-ventilated place, away from incompatible materials, to account for its volatile nature. Stability is maintained via the added Thymol stabilizer.
Safety Access The container must be kept out of reach of children and stored locked up in compliance with official safety guidelines.
Disposal Do not empty into drains or wastewater. Unused product and waste material must be sent to an appropriate treatment and disposal facility according to local, regional, and national regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Anestane found in:

A-Z Index: